During the past decade, Swan Urogynecology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Swan Urogynecology" are "Pelvic Organ Prolapse" (3 trials). Many other conditions were trialed in "Swan Urogynecology" in a lesser frequency.

Most popular intervention types in "Swan Urogynecology" are "Device" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Native Tissue Repair for pelvic organ prolapse" (2 trials), "Elevate Anterior and Apical" (1 trials), "Elevate Apical and Posterior" (1 trials), "Native Tissue Repair Anterior" (1 trials) and "Native Tissue Repair Posterior" (1 trials). Other intervention names were less common.

The vast majority of trials in "Swan Urogynecology" are 3 trials for "Female" genders.

Currently, there are NaN active trials in "Swan Urogynecology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Swan Urogynecology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Swan Urogynecology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".